ImportantCompany Update
The company has announced a board meeting on October 26. The key agenda for this meeting is to review and approve the financial results for the quarter and half-year.
Asston Pharmaceuticals Ltd544445 · Filed with the exchange
This is a crucial update for investors, offering insights into the company's recent operational and financial performance.
Additionally, the Board will consider a proposal for a rights issue of equity shares.
This potential capital raise could impact the company's capital structure and fund future growth, providing important clarity on funding plans and shareholder opportunities.
No comments yet. Be the first.